RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

391 hedge funds and large institutions have $8.7B invested in Royalty Pharma in 2024 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 157 increasing their positions, 122 reducing their positions, and 40 closing their positions.

Holders
391
Holders Change
+16
Holders Change %
+4.27%
% of All Funds
5.66%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.13%
New
59
Increased
157
Reduced
122
Closed
40
Calls
$20.8M
Puts
$1.47M
Net Calls
+$19.4M
Net Calls Change
+$10.1M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$123M
2
Amundi
2
Amundi
France
$101M
3
Deutsche Bank
3
Deutsche Bank
Germany
$66.3M
4
Charles Schwab
4
Charles Schwab
California
$84.9M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$337M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$36.5M
2
UE
2
Unisphere Establishment
Liechtenstein
$0
3
Norges Bank
3
Norges Bank
Norway
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$1.16B
5
Aberdeen Group
5
Aberdeen Group
United Kingdom
$2.93M
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$1.16B 41,078,163 -3,055,283 -7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.06B 37,585,123 -437,258 -1%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$789M 27,890,143 +3,442 +0%
BlackRock
4
BlackRock
New York
$631M 22,301,159 -716,402 -3%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$456M 16,122,491 -230,268 -1%
Viking Global Investors
6
Viking Global Investors
Connecticut
$342M 12,094,021 +123,963 +1%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$337M 11,899,194 +967,263 +9%
Swedbank
8
Swedbank
Sweden
$312M 11,027,370 +213,900 +2%
State Street
9
State Street
Massachusetts
$269M 9,516,262 +29,451 +0.3%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$206M 7,265,786 +417,490 +6%
Millennium Management
11
Millennium Management
New York
$123M 4,341,505 +1,991,225 +85%
Amundi
12
Amundi
France
$101M 3,691,255 +1,627,093 +79%
SGA
13
Siguler Guff Advisers
New York
$96M 3,391,754 – –
GC
14
GMT Capital
Georgia
$87.6M 3,097,500 +670,400 +28%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$85.8M 3,033,200 +936,900 +45%
Charles Schwab
16
Charles Schwab
California
$84.9M 3,001,603 +1,103,341 +58%
UBS AM
17
UBS AM
Illinois
$84.1M 2,972,201 +174,874 +6%
Northern Trust
18
Northern Trust
Illinois
$83.6M 2,953,810 -343,467 -10%
Legal & General Group
19
Legal & General Group
United Kingdom
$73.2M 2,587,852 +27,423 +1%
NSCM
20
New South Capital Management
Tennessee
$69.8M 2,466,371 +117,394 +5%
Two Sigma Investments
21
Two Sigma Investments
New York
$68.7M 2,429,336 +371,796 +18%
Deutsche Bank
22
Deutsche Bank
Germany
$66.3M 2,342,260 +1,362,476 +139%
PCM
23
Patient Capital Management
Maryland
$57.7M 2,041,195 +616,805 +43%
Bank of America
24
Bank of America
North Carolina
$57.6M 2,034,705 +16,110 +0.8%
Mitsubishi UFJ Trust & Banking
25
Mitsubishi UFJ Trust & Banking
Japan
$56.8M 2,006,306 +175,439 +10%
1
2 3 4 5